To study the safety and feasibility of the CarpX device to divide and release the transverse carpal ligament in order to provide relief for Carpal Tunnel Syndrome (CTS).
This is a prospective, single center, single arm, study of the CarpX device for treatment of carpel tunnel syndrome. Patients will be followed for up to 30 days post procedure.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
20
Transverse carpal ligament release with CarpX Device
Christchurch Hospital
Christchurch, New Zealand
Device Safety defined as freedom from Serious Adverse Events probably or definitely related to the CarpX device resulting in significant morbidity.
Freedom from Serious Adverse Events probably or definitely related to the CarpX device resulting in significant morbidity.
Time frame: Through 30-day
Device Technical Success: defined as the ability of the CarpX Device to perform complete division of the transverse carpel ligament.
Defined as the ability of the CarpX Device to perform complete division of the transverse carpel ligament.
Time frame: Through 30-day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.